AcrySof® IQ Monofocal and AcrySof® IQ Toric IOL
The trusted IOL that gives you complete confidence
AcrySof® IQ Monofocal and AcrySof® IQ Toric IOL
The trusted IOL that gives you complete confidence
AcrySof® IQ Monofocal IOLs Give You Complete Confidence You Made The Right Choice
Low PCO and Nd: YAG Rates1-7
Frees up capacity by reducing secondary treatments
Excellent Quality of Vision1,8-12,16-19
Proven long-lasting visual outcomes
Trusted by Surgeons20,21
125 million implants worldwide
Clinically Proven to Have the Lowest PCO and Nd: YAG rates at 3 and 5 years2*
In a study conducted in more than 600,000 eyes, AcrySof® IQ showed reduced PCO and the lowest Nd:YAG rates, compared to single-piece and hydrophilic IOLs.
Unprecedented data demonstrates that AcrySof® IQ reduces Nd: YAG treatment3-6
Multiple studies conducted across various countries reveal why AcrySof® IQ should be the right IOL choice.
Reduced development of PCO
AcrySof® IQ material promotes clear capsules and reduces secondary treatments:1,7
- Unique AcrySof® IQ hydrophobic acrylic material provides the highest bonding with the capsule compared to competitor IOLs.
- Proprietary edge design helps to block cell migration between the optic and the capsular bag.
Excellent Quality of Vision
AcrySof® IQ BioMechanics provide excellent refractive outcomes
*Trademarks are the property of their respective owners.
Available in two filtering properties that mimic the natural human lens1,16,17
UV and Blue light filter
Proprietary chromophore that can help filter harmful light sources, similar to the healthy human lens1,16
The AcrySof® IQ blue light filter can provide patients with a greater tolerance for extreme bright light as well as faster visual recovery after high bright light exposure1,17,18
UV filter
The only IOL that provides 100% UV filter protection. Other IOLs* allow for parts of UVA radiation to pass through the IOL to the retina1,12-15
*Other IOLs include J&J Tecnis†, HOYA NY60†, and B&L Envista†. See UV filter chart below for further details.
†Trademarks are the property of their respective owners.
AcrySof® IQ IOLs can help patients manage situations they encounter every day, including challenging driving conditions.1,17,18*†
- Greater tolerance for extreme bright light16-18
- Faster visual recovery after high bright light exposure16-18
Improved Performance in Challenging Conditions
*A subset of patients (n = 44) underwent testing in a validated night driving simulator. Patients were tested monocularly under conditions which simulate city and rural settings under normal, glare and fog conditions.
†AcrySof® IQ IOL patients had an average increase of 40+ metres feet versus the control lens in which to stop after identifying a warning sign in a rural setting under fog conditions at 88 km/h.
BioOptics Provides Highest Level of UV Protection1
The only IOL that provides 100% UV filter protection. Other IOLs allow for parts of UV-A radiation to pass through the IOL to the retina1,12-15
Fully usable optic helps reduce visual disturbances
The AcrySof® IQ aspheric optic surface is designed to reduce edge glare.1
AcrySof® (SN60WF)
6 mm fully usable aspheric optic1,19
TECNIS* 1-Piece (ZCB00)
4.9 mm limited usable aspheric optic13,19
enVista* (MX60)
4.9 mm limited usable aspheric optic15,19
*Trademarks are the property of their respective owners
Trusted by Surgeons Worldwide
AcrySof® IQ features proven technology for a confidence that has been truly earned.
RANKED #1
in surgical
IOLs20
125+ MILLION
AcrySof® IOLs
implanted
worldwide21
25+ YEARS
proven safety and
effectiveness
BACKED BY
unprecedented
clinical data
AcrySof® IQ IOLs are available in the best-in-class UltraSert® Preloaded Delivery System.
Proven Stability and Exceptional Performance with AcrySof® IQ Toric IOL
AcrySof® IQ Toric IOLs had significantly lower incidence of repositioning compared to other IOLs23
Alcon Online Toric IOL Calculator features the Barrett Algorithm
Offer Your Patients Astigmatism Correction with Proven Stability22,23
Vision Simulation: Daytime Activity with Moderate Astigmatism
AcrySof IQ and Toric IOL Clinical Studies
Technical Specifications1
ACRYSOF® IQ MONOFOCAL
ACRYSOF® IQ TORIC
*This number represents a 2020 update using this SRK/T formula. Unless otherwise noted, this suggested A-constant is presented as a guideline and is a starting point for implant power calculations.
ACRYSOF® SINGLE PIECE
ACRYSOF® MULTIPIECE
Instructions for Use (IFU)
For a full list of indications, contraindications and warnings, please visit ifu.alcon.com and refer to the relevant product’s instructions for use.
Alcon Experience Academy
For relevant training content from industry thought leaders
References:
1. AcrySof® IQ Directions For Use.
2. RCOphth National Ophthalmology Database Audit Feasibility Study of Post-cataract Posterior Capsule Opacification https://www.nodaudit.org.uk/u/docs/20/rijbxkcubs/RCOphth%20NOD%20PCO%20Report%202021.pdf Accessed 14 July 2021.
3. Ursell PG, Dhariwal M, O'Boyle D, Khan J, Venerus A. 5 year incidence of YAG capsulotomy and PCO after cataract surgery with single-piece monofocal intraocular lenses: a real-world evidence study of 20,763 eyes. Eye (Lond). 2020 May;34(5):960-968.
4. Belda J, Placeres J, Elvira J, O’Boyle D, Puig X, Vives CP, et al. Is Nd:YAG capsulotomy incidence influenced by IOL biomaterial? Real-word evidence from Spain at 3 & 5 years after cataract surgery. Free Paper
5. Lindholm JM, Laine I, Tuuminen R. Five-Year Cumulative Incidence and Risk Factors of Nd:YAG Capsulotomy in 10 044 Hydrophobic Acrylic 1-Piece and 3-Piece Intraocular Lenses. Am J Ophthalmol. 2019 Apr;200:218-223.
6. Thom H, Ender F, Samavedam S, Perez Vivez C, Gupta S, Dhariwal M, de Haan J, O'Boyle D. Effect of AcrySof versus other intraocular lens properties on the risk of Nd:YAG capsulotomy after cataract surgery: A systematic literature review and network meta-analysis. PLoS One. 2019 Aug 19;14(8):e0220498.
7. Ong M, Wang L, Karakelle M. Fibronectin adhesive properties of various intraocular lens materials. Alcon Laboratories, Fort Worth, TX, USA. ARVO 2013.
8. Wirtitsch MG, Findl O, Menapace R, Kriechbaum K, Koeppl C, Buehl W, Drexler W. Effect of haptic design on change in axial lens position after cataract surgery. J Cataract Refract Surg. 2004 Jan;30(1):45-51.
9. Nejima R, Miyai T, Kataoka Y, Miyata K, Honbou M, Tokunaga T, Kawana K, Kiuchi T, Oshika T. Prospective intrapatient comparison of 6.0-millimeter optic single-piece and 3-piece hydrophobic acrylic foldable intraocular lenses. Ophthalmology. 2006 Apr;113(4):585-90.
10. Lane, S, Collins, S, Das, K et al. Evaluation of intraocular lens mechanical stability. J Cataract Refract Surg. 2019;45(4):501-506.
11. Alcon Data on File, 2017. [TDOC-0054028]
12. Mainster MA. Spectral transmittance of intraocular lenses and retinal damage from intense light sources. Am J Ophthalmol. 1978 Feb;85(2):167-70.
13. Tecnis 1-piece IOL with the Tecnis iTec Preloaded Delivery System Directions For Use. Johnson & Johnson Vision.
14. HOYA NY-60 Direction For Use. HOYA Corporation.
15. EnVista hydrophobic acrylic intraocular lens Directions For Use. Bausch & Lomb.
16. Landers JA, Tamblyn D, Perriam D. Effect of a blue-light-blocking intraocular lens on the quality of sleep. J Cataract Refract Surg. 2009 Jan;35(1):83-8.
17. Gray R, Perkins SA, Suryakumar R, Neuman B, Maxwell WA. Reduced effect of glare disability on driving performance in patients with blue light-filtering intraocular lenses. J Cataract Refract Surg. 2011 Jan;37(1):38-44.
18. Hammond BR Jr, Renzi LM, Sachak S, Brint SF. Contralateral comparison of blue-filtering and non-blue-filtering intraocular lenses: glare disability, heterochromatic contrast, and photostress recovery. Clin Ophthalmol. 2010;4:1465-1473.
19. Alcon Data on File, 2017. TDOC-0053803 - Imaging of the Usable Optic Diameter of Clareon SY60WF, Tecnis ZCB00, and enVista MX60 Intraocular Lenses.
20. Based on 2020 sales reported in Market Scope, GfK, Nielsen, IQVIA, Euromonitor, and Alcon internal estimates.
21. Alcon sales data since 1993.
22. Oshika T, Fujita Y, Hirota A, et al. Comparison of incidence repositioning surgery to correct misalignment with three toric intraocular lenses. Eur J Ophthalmol. 2019. doi:10.1177/1120672119834469.
23. Lee BS, Chang DF. Comparison of the rotational stability of two toric intraocular lenses in 1273 consecutive eyes. Ophthalmology. 2018;125(9):1325-1331.
Please refer to the relevant product direction for use for list of indications, contraindications and warnings.